Three glaucoma-associated mutations, E50K, M98K, and H486R; an ALS-associated mutation, E478G; two synthetic OPTN mutations, F178A and D474N, disrupting LC3b and ubiquitin binding, respectively. Here, MAP1LC3B is linked to glaucoma.